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Abstract
A clonally derived (or “monoclonal”) cell line is a cell population derived from a single
progenitor cell. Clonally derived cell lines are required for many biotechnological
applications. For instance, recombinant mammalian cells used to produce ther-
apeutic proteins are expected by regulatory authorities to be clonally derived.
Assurance of clonal derivation (or “clonality”) is usually obtained from the char-
acterization of the procedure used for cell cloning, for instance by assessing the
success rate of single‐cell sorting but not by assessing the cell line itself. We have
developed a method to assess clonal derivation directly from the genetic makeup of
cells. The genomic test of clonality is based on whole‐genome sequencing and
statistical analysis of single nucleotide variants. This approach quantifies the clonal
fractions present in nonclonal samples and it provides a measure of the probability
that a cell line is derived from a single cell. Upon experimental validation of the test,
we show that it is highly accurate and that it can robustly detect minor clonal
fractions of as little as 1% of the cell population. Moreover, we find that it is
applicable to various cell line development protocols. This approach can simplify
development protocols and shorten timelines while ensuring clonal derivation with
high confidence.
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1 | INTRODUCTION
Recombinant cell lines used to produce biologics for therapeutic use
should be clonally derived (i.e., “monoclonal”), that is they should
derive from a single progenitor cell. Specifically, regulatory autho-
rities expect that master cell banks (i.e., the cell line used for man-
ufacturing) be thoroughly documented for their clonal derivation.
The rationale for this requirement is that such a cell bank is
genetically more homogeneous, which can improve the consistency
and robustness of recombinant protein. In contrast, if several clonal
populations are present within the cell line, potential changes in
manufacturing conditions could put selective pressure on the cells,
possibly resulting in modified clonal composition and variations or
heterogeneity of the final product (Welch & Arden, 2019).
Most efforts geared at ensuring clonal derivation (or “mono-
clonality”) have relied on characterizing single‐cell cloning
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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procedures. Hence, from the classical limiting dilution method to the
recent development of microfluidic chips to sort single cells in-
dividually, every new technology has improved the effectiveness of
single‐cell cloning. In contrast, direct assessment of clonal derivation
based on the analysis of the recombinant cell line itself has witnessed
few improvements. Indeed, until recently, molecular genetic methods
that could help to assess clonality directly were very laborious (e.g.
analyzing transgene integration sites) or had poor resolution (e.g.
Southern blots). The advent of high‐throughput sequencing, however,
has opened new possibilities.
High‐throughput DNA sequencing‐based methods can now
readily identify transgene integration sites. When transgene in-
tegration is random, integration sites can be used as a unique genetic
feature of the cell line, that is as a clonal signature. The clonal deri-
vation of a cell line can thus be established by verifying that the
specific integration site is homogeneously present in the population.
For instance, Aebischer‐Gumy, Moretti, Little, and Bertschinger
(2018) have assessed cell line clonality by generating individual
subclones and by verifying that a large number of these subclones
contained the same specific genome‐transgene junction.
Over the last years, however, it has become increasingly clear
that even clonally derived cell lines can gradually become genetically
heterogeneous. Indeed, several studies have shown that subclones
from the same cell line can display different phenotypic behaviors
(Ko et al., 2018; Patel et al., 2018; Tharmalingam et al., 2018). In
addition, clonally derived cell lines have been shown to display ge-
netic evolution affecting their genome at various scales (from the
accumulation of point mutations to chromosomal rearrangements),
as well as epigenetic changes (Feichtinger et al., 2016; Vcelar
et al., 2018). However, a systematic understanding of how genetic
and epigenetic changes relate to phenotypic characteristics of a cell
line is lacking.
Here, we show that non‐clonal cell lines can be efficiently de-
tected based on the genome‐wide analysis of its single nucleotide
variants (SNVs). Building on this principle, we developed and vali-
dated a formal statistical procedure for testing clonal derivation
named genomic test of clonality (GTC). We derived the minimal re-
quirements needed to ensure the high sensitivity of the test. We also
show that this procedure is very robust and that it does not depend
on details of either the sequencing technology or the bioinformatic
analysis used for the identification of SNVs for instance. Importantly,
we demonstrate that it can be efficiently integrated in the context of
commercial cell line development, even in the case of procedures
involving multiple successive subcloning steps.
2 | MATERIALS AND METHODS
2.1 | Cell lines, whole‐genome sequencing and
detection of SNVs
All cell lines used here were derived from the Chinese hamster ovary
(CHO) host cell line HCB‐2 (Selexis SA), except for the cell lines SG
and FG that were derived from the host cell line HCB‐1 (Selexis SA).
Both HCB‐1 and HCB‐2 lines were obtained from the CHO‐M
(Selexis SA) cell line, originally derived from a CHO‐K1 line. Con-
struction of expression vectors, transfection conditions, and cell
culture conditions were previously described (Grandjean et al., 2011;
Le Fourn, Girod, Buceta, Regamey, & Mermod, 2014). The details of
sample preparation for all experiments presented here are provided
in the Supporting Information.
Sample‐specific SNVs are SNVs that can be detected in the
tested cell line (e.g. with a frequency >0.05, i.e., 5%) but that have
very low frequency in the parental population. We performed whole‐
genome sequencing using Illumina technology and detected sample‐
specific SNVs using standard bioinformatics methods (see the
Supporting Information), including the R/Bioconductor package
VariantTools (Lawrence, Degenhardt, & Gentleman, 2019). Restrict-
ing to SNVs that are very rare in the parental population allows us to
measure clonal fractions in the tested population. Specifically, it en-
sures that if there are two progenitor cells (in the event of failed cell
cloning), the probability that they will each contain a different, spe-
cific set of SNVs is very high (see Section 2.2.1). Specifically, we
selected all SNVs that were present in the tested cell line and un-
detected in the parental cell population (i.e., no variant allele ob-
served). Considering the high sequencing depth used for HCB‐2, this
corresponds to SNVs with variant allele frequencies <0.05. More-
over, we restricted sample‐specific SNVs located in regions that were
present in a single copy in the genomes of both the tested cell po-
pulation and the parental cell line. As fixation of such SNVs results in
allele frequencies of one (whereas fixation of an SNV located in a
2‐copy region results in an allele frequency of 0.5), this facilitates
the estimation of clonal fractions from the parametric model (see
Section 2.2.2).
2.2 | Genomic test of clonality
2.2.1 | Parametric model
Let us consider SNVs that are specifically detected in the cell po-
pulation tested for clonal derivation. Each SNV is characterized by
the coverage cd (i.e., the total number of sequencing reads covering
the genomic position) and the number of sequencing reads carr-
ying the variant allele ad (also referred to as the alternative allele
count). The frequency of a variant is defined as the ratio ad/cd. We
assume that each SNV is specific to a given clone, that is a given SNV
cannot be present in two clonal subpopulations in the case of a clonal
mixture (see “Verification of model specification” in the Supporting
Information for the assessment of this assumption). For a given SNV
in a 1‐copy region of the genome, ad is modeled as a variable from a
Binomial distribution with parameters cd (number of trials) and
f (probability, corresponding to the fraction of the clone in the cell
population). In other words, ad is distributed as the number of
“successes” (i.e., reads carrying the variant allele) in a series of cd
independent experiments (i.e., the total number of reads covering
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that genomic location), each with probability f to “succeed” (i.e., the
read originates from the clonal population carrying the variant allele).
In addition, the coverage cd varies across SNVs and it can be modeled
as a variable from a Poisson distribution (Lander & Waterman, 1988)
with parameter C (true average coverage). Thus, considering the set
of SNVs corresponding to a given clone, the alternative allele count
ad can be modeled as a Binomial distribution (i.e., the probability of
observing the alternative allele count for a fixed coverage) com-
pounded by the Poisson‐distributed coverage (see e.g. Ocerin &
Pérez, 2002). This compound distribution is another Poisson dis-
tribution with parameter C * f (true average coverage times clonal
fraction). Finally, if we assume that the cell population is composed of
two clones, we can model the variant allele count for all SNVs in the
population as a mixture of two Poisson distributions (with para-
meters C * f and C * (1 − f), respectively, see Figure S1a).
2.2.2 | Parameter estimation
We aim to estimatef from the parametric mixture model described
above. In the present case, directly fitting a mixture of Poisson dis-
tributions is unpractical, however, because the alternative allele
count distribution is usually left truncated (at the minimal number of
reads set to detect SNVs reliably, e.g. here four reads) or con-
taminated by artefactual SNVs. To circumvent this problem, we de-
veloped a 2‐step procedure: We obtain an initial estimate of f that
allows for the detection of balanced to moderately unbalanced (e.g.
f = 0.5–0.8) clonal mixtures without making any assumption. Based
on this initial measure, we next determined a second, very accurate
measure of f for mixtures with larger major clonal fractions (and
correspondingly smaller minor fractions). This refined measure of f
provides the high sensitivity needed to detect highly unbalanced
samples.
The initial estimate of f is obtained by fitting the upper compo-
nent of the Poisson mixture only. Specifically, we fit a single, trun-
cated Poisson distribution, whose truncation level is given by half the
mean coverage (i.e., cd̅/2), allowing to estimate C * f (Figure S1b). The
fraction of the majority clone f is given by fpois = (C * f)/cd̅. This initial
measure of f allows us to efficiently and safely reject monoclonality in
the cases of clonal mixtures that are not too unbalanced. When
clonal ratios are greater than approximately 80/20, however, we can
obtain a more accurate measure of f by identifying SNVs from the
majority clone and fitting them specifically, hence removing the
mixture problem. We define the two Poisson component distribu-
tions as “separable” when their overlap is small enough such that the
probability of making an error when assigning each allele count (i.e.,
SNV) to a clonal subpopulation has a fixed upper bound (specifically,
if there is a count value such that at least 95% of counts from the
majority clone are strictly greater and at most 5% of counts from the
minority clone are strictly smaller, see Figure S1a). Separability de-
pends on SNV coverage: the higher the coverage, the greater the
separability (conversely, if coverage is low, e.g. <5, even two clones
with a very unbalanced clonal ratio, e.g. 90/10, will not be separable).
If the initial Poisson‐based measure fpois is greater than the minimal
fraction ensuring separability (for the observed average coverage cd̅)
(Figure S1c), we identify SNVs from the majority clone and use them
to calculate the more accurate, Binomial‐based measure of f. For a
typical average coverage of 13, the minimum (true) f allowing se-
parability is 0.81.
SNVs from the majority clone are identified as follows (Figure
S1d): for each SNV coverage value, we determine the count value
such that when most of the allele counts (i.e., at least 99%) of the
distribution from the majority clone (modelled as Binomial with
parameters cd and fpois) are included, the probability of having an
allele count of the distribution of the minority clone (modelled as
Binomial with parameters cd and 1 − fpois) above this count value is
upper bounded (at most 5%). Thus, SNVs with counts above this
boundary are confidently assigned to the majority clone (Figure S1d).
When restricting to SNVs identified as originating from the majority
clone, we obtain a more accurate measure of f as follows: as the
probability parameter of these Binomial variables is identical, their
sum (∑ad) follows a Binomial distribution with parameters∑cd and f,
and f is thus given by fbinom =∑ /∑a cd d. We finally used the Agresti‐
Coull method to calculate a confidence interval for this binomial
fraction estimate. A sample is called (clonally) pure only if the lower
limit of the Agresti‐Coull confidence interval for fbinom is >0.99 (see
“Operational threshold for clonal purity” in the Supporting Informa-
tion). All statistical procedures were implemented using the R soft-
ware (R Core Team, 2020).
2.2.3 | p‐value for clonal derivation
For a cell population that is deemed clonally pure, we can obtain a
p‐value corresponding to the hypothesis that it is derived from a
single progenitor cell (i.e., clonal derivation, or monoclonality). For
the sake of illustration, let us first consider a single individual SNV
that is rare in the parental population and becomes fixed upon cell
cloning. If single‐cell cloning fails and there are two progenitor cells
instead of 1, we will wrongly call the population clonally derived if,
and only if, the second cell bears the same SNV. If we assume that the
two progenitor cells are randomly drawn from the population, the
probability that the second cell bears the same SNV is given by its
population frequency. This frequency thus formally corresponds to a
statistical p‐value for clonal derivation (i.e., the probability of making
an error if we accept the null hypothesis that the population is
clonally derived).
If we now consider more than 1 fixed SNV in the derived po-
pulation, the probability that the exact same set of SNVs is carried by
the second progenitor cell is bound to be lower than the probability
obtained with a single SNV, such that the confidence of clonal deri-
vation is higher. Formally, the p‐value corresponding to the smallest
SNV frequency observed in the parental population corresponds to
the upper bound (i.e., conservative estimate) of the true p‐value.
In practice, the measurement of SNV frequency via standard
sequencing library preparation and sequencing has a limited
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resolution. Owing to the intrinsic per‐base error in the current best
standard sequencing technologies, the limit of rare variant detection
is (conservatively) estimated at 0.05. This limit can be reached with a
sequencing depth >50×–100× and higher sequencing depths do not
improve the sensitivity of detection. Here, we thus performed deep
sequencing of the host cell population (i.e., 150× for HCB‐2) and
considered that if we did not observe a single alternative allele in the
parental population (i.e., for an SNV fixed in the derived population),
it had a frequency <0.05, yielding a p‐value for clonal derivation
<0.05. Importantly, we have shown that SNVs fixed in derived cell
lines are at least ×10 rarer than this (i.e., <0.005, see “Verification of
model specification” in the Supporting Information). This implies
again that in the present application of GTC, the true p‐value for
clonal derivation is significantly less than the upper bound of 0.05.
3 | RESULTS
3.1 | Characterization of the genetic diversity in
parental host cells and in clonally derived cell lines
In the process of producing a new cell line for recombinant protein
production, a cell population (i.e., the “host” or “parental” population)
is transfected with a vector directing the expression of the re-
combinant protein. A single cell is isolated from that population and
gives rise to the new cell population (i.e., the derived cell line) upon
cell divisions (Figure 1a). If there is abundant genetic diversity in the
host cell line, the single‐cell cloning step is expected to result in a
dramatic decrease in the genetic diversity of the derived cell line as
compared to the host cell line: mutations contained in the progenitor
cell will be inherited by daughter cells, whereas other genetic var-
iants present in the host cell line will be absent from the derived cell
line. In contrast, if cell cloning fails and two progenitor cells lead to a
non‐monoclonal cell line, the derived population will contain two cell
subpopulations that each inherited from the genetic variants con-
tained in the corresponding progenitor cell (Figure 1c).
Here, we specifically consider the genetic diversity provided by
SNVs but the argument holds true for other types of mutations as
well. The difference in the genetic makeup of a population originating
from one or two progenitor cells is reflected in the SNV frequency
spectrum of the derived population. In the case of a single progenitor
cell, all SNVs are fixed and thus have a population frequency of 1
(Figure 1b) whereas if there are two progenitor cells and each cell
bears specific SNVs, the SNVs in the derived population are present
in only half of the cells and thus have a frequency of 0.5 (Figure 1d).
We will show that this difference can provide the basis for a formal
test of clonality.
To verify our assumptions, we first characterized SNVs in a
standard host cell line (CHO‐K1 derivative) that is routinely used to





F IGURE 1 Schematic representation of genetic diversity in a host cell line and derived cell lines. (a) Cells in the host cell line contain a
variety of rare mutations (specifically single nucleotide variants (SNVs), represented as color ticks on the chromosomes). The genome is depicted
as a single pair of chromosomes for simplicity. Upon cell cloning SNVs harbored by the progenitor cell (and represented by the blue, green,
and yellow ticks) are inherited by all daughter cells and thus become fixed in the clonally derived cell line. (b) Population frequency of
SNVs in the clonally derived cell line (represented in panel a) showing that three SNVs are detected with a population frequency of 1 (i.e.,
present in all cells). (c) Non‐monoclonal cell line derived from two progenitor cells. Each progenitor cell contains specific SNVs and the derived
cell line is composed of two subpopulations that are each derived from one of the progenitor cells. (d) Population frequency of SNVs in the
derived non‐monoclonal cell line (represented in panel c) showing six SNVs each with a population frequency of 0.5 (i.e., present in half of the
cells) [Color figure can be viewed at wileyonlinelibrary.com]
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clonally derived cell line. Both samples were subjected to whole‐
genome sequencing and SNVs were detected using standard bioin-
formatics methods. The vast majority of SNVs detected in the host
cell line were low‐frequency (<0.2, i.e., 20%) mutations whereas
the derived cell line indeed contained many newly fixed mutations
(Figure S2), as anticipated.
3.2 | Cell lines derived from one or from two
progenitor cells display different SNV frequency
spectra
We, then, explored the detection of clonality based on the analysis of
SNV frequencies using clonal mixtures generated in silico. Specifi-
cally, we subjected two clonally derived cell lines to whole‐genome
sequencing and generated mixed samples by combining their se-
quencing data. To obtain a sample mimicking a balanced (50/50)
clonal mixture (corresponding to the hypothetical case illustrated in
Figure 1c,d), we pooled equal proportions of reads from each of the
two clonally derived cell lines (Figure 2a). The analysis of this mixed
sample revealed that sample‐specific SNVs had frequencies centered
around 0.5, as anticipated.
We repeated the mixing procedure to generate samples mi-
micking clonal mixtures of varying ratios (80/20 and 95/5 in
Figure 2b and 2c, respectively). Upon detection of SNVs, we ob-
served fewer SNVs with frequency around 0.5 and relatively more
SNVs with lower (<0.5) or higher (>0.5) frequencies. This reflects the
underlying presence of two SNV clusters: The lower cluster origi-
nates from SNVs fixed in the cell line representing the minor clonal
fraction, whereas the higher SNV cluster contains SNVs fixed in the
cell line representing the majority clone (see also Figure S3). More-
over, the greater the fraction of the majority clone, the greater the
number of high‐frequency SNVs. In conclusion, the analysis of SNVs
can reveal the presence of two clonal populations even when un-
balanced and their frequencies provide quantitative information on
clonal fractions.
3.3 | The genomic test of clonality (GTC) has high
accuracy and sensitivity
Building on the statistical analysis of SNVs, we developed an accurate
measure of the clonal fractions (potentially) present in a cell popu-
lation and derived a measure of the probability that the cell line is
clonally derived (i.e., p‐value for clonal derivation, or “monoclonality”)
(see Section 2 and Figure S4). The procedure relies on the whole
genome sequencing of the cell line and its corresponding host cell
population. Subsequent bioinformatic analysis allows us to identify
SNVs that are specific to the derived cell line (i.e., SNVs that have
very low frequency in the parental population). The detected SNVs
are then used to run GTC, which involves two steps: First, we fit a
parametric model that yields measures of clonal fractions. If the cell
population is deemed pure (clonal homogeneity), the second step
calculates a p‐value for clonal derivation. Specifically, we test the
hypothesis that the cell population is derived from a single progenitor
cell. In the terms of statistical inference, the p‐value thus is the
probability that the cell population is not clonally derived and actu-
ally derives from two progenitor cells bearing the same SNVs (indeed,
(a) (b) (c) (d)
F IGURE 2 Simulation of mixed clonal populations and analysis of their single nucleotide variant (SNV) frequency spectra. Sequencing reads
originating from whole‐genome sequencing of two clonally derived cell lines (represented by blue and green rectangles) were combined to
simulate clonal mixtures presenting varying ratios of the two cell lines. Each mixture was subjected to SNV analysis and the corresponding SNV
frequency spectrum is represented at the bottom. The ratio of the two cell lines in each artificial sample is as follows (percentage of green cell
line/percentage of blue cell line): (a) 50/50, (b) 80/20, (c) 95/5, (d) 100/0 (monoclonal population) [Color figure can be viewed at
wileyonlinelibrary.com]
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if the two progenitor cells do not carry the same SNVs, clonal het-
erogeneity is detected in the first step of GTC).
We tested the accuracy of the clonal fractions measured by GTC
and the sensitivity of the method using a cellular mixing experiment.
In short, cells from two clonally derived cell lines were mixed in
various ratios (Figure 3a) to determine what was the lowest minor
clonal fraction that GTC could robustly detect. We analyzed the
following mixed populations (percentage of major clone/percentage
of minor clone): 95/5, 98/2, 99/1, and 100/0 (i.e., a pure clone). To
independently verify the actual clonal proportions in the mixed
samples, one of the two clonal populations was stained beforehand
so that sample composition could be independently measured using
flow cytometry. Finally, each mixed sample was subjected to whole‐
genome sequencing and analyzed using GTC in a blinded fashion. It is
important to highlight that the identity of SNVs fixed in each of the
two clones was not known a priori to GTC.
Analysis of the mixed samples showed that SNVs yield a strong
and robust signal for clonality assessment (Figure 3b). As the fraction
of the major clone increased from 95% (Sample 1) to 100% (Sample
4), the distribution of SNV frequencies gradually shifted to the right
towards 1. Based on these SNVs, GTC could infer measures of clonal
fractions (along with tight confidence intervals, as shown at the top
of each barplot in Figure 3b). Samples 1–3 were deemed clonally
heterogeneous and thus non‐monoclonal. Sample 4 presented mostly
fixed SNVs and was deemed (clonally) pure and clonally derived
(p < .05). Comparison with parallel flow cytometry‐based measure-
ments showed that the clonal fractions obtained with GTC were at
least as accurate (Figure 3c). Notably, GTC could differentiate be-
tween samples composed of 99% of a clone (Sample 3) and the
corresponding pure sample (Sample 4), demonstrating that it can
robustly detect minor fractions of contaminating cells as low as 1%.
3.4 | Validation of GTC in the context of cell line
development
We asked if GTC could be applied to assess clonality in the context of
routine cell line development. Our standard platform is based on the
use of the ClonePix FL (Genetix). We thus performed a standard
single‐cell cloning procedure involving plating a cell suspension in
semi‐solid medium and automated colony picking following strict
imaging criteria. Instead of a transfected cell population, however, we
(a) (c)
(b)
F IGURE 3 Experimental validation of clonal fractions measured by the genomic test of clonality (GTC). (a) We experimentally mixed two
clonally derived cell lines in varying cellular proportions and applied GTC to measure clonal fractions. Cells from one cell line were stained
beforehand and the actual cellular composition in each mixture was measured by flow cytometry as well. (b) Single nucleotide variant (SNV)
frequency spectra, clonal fractions, corresponding confidence intervals, and pvalue for clonal derivation provided by GTC analysis for three
highly unbalanced samples and a pure sample. GTC deemed Samples 1–3 as clonally heterogeneous (non‐monoclonal) and Sample 4 as clonally
pure and clonally derived (p < .05). (c) Comparison of clonal fractions measured by GTC and by flow cytometry. The bars represent confidence
intervals [Color figure can be viewed at wileyonlinelibrary.com]
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used a mixture of two clonally derived cell lines selected for growing
at extremely fast and slow rates (referred to as fast grower, or FG,
and slow grower, or SG, see “Preparation and detection of non‐clonal
colonies during cell line development” in Supplementary Methods).
This was performed to mimic the dilution of slow‐growing cells cul-
tured within a population of fast‐growing ones, to ascertain that a
mix of two clones growing at highly different speeds could effectively
be distinguished using GTC (Figure 4a). Using previously established
diagnostic PCR assays designed to identify each of the FG and SG
clones, we screened the picked colonies for non‐clonal samples
showing both the FG‐ and SG‐specific amplicons (Figure 4b), as op-
posed to clonal samples showing either the FG‐ or SG‐specific
amplicon. Given the very rare occurrence of non‐clonal colonies
under standard operating conditions used for cell cloning, we in-
tentionally increased the cell density used to seed semi‐solid medium
to decrease the number of colonies that needed to be screened to
find non‐clonal ones. Finally, we subjected several clonal and non‐
clonal samples to whole‐genome sequencing and GTC in a blinded
manner.
Without a priori information about the FG and SG cell lines, GTC
correctly identified clonal (i.e., pure) and non‐clonal (i.e., mixed)
samples, in line with the PCR screen (Figure 4c). Given that the FG
cell line had a shorter doubling time, we expected to obtain a much




F IGURE 4 Validation of genomic test of clonality (GTC) in the context of cell line development using an automated cloning and imaging system.
(a) A cell suspension composed of two clonally derived cell lines (named FG and SG) was plated in semi‐solid medium. Ten days later, individual
colonies were picked according to standard imaging criteria. Colonies were screened by polymerase chain reaction (PCR) to identify clonal and
non‐clonal colonies. Selected clonal and non‐clonal samples were subjected to GTC and quantitative PCR (qPCR). (b) Result of the PCR screen. Gel
electrophoresis analysis of four samples showing FG‐specific amplicon only (Samples 1 and 3), SG‐specific amplicon only (Sample 2) or both
amplicons simultaneously (Sample 4), hence revealing a colony composed of both clones. Green rectangles highlight samples displayed in panel c.
(c) Single nucleotide variant (SNV) frequency spectra and results of GTC applied to Samples 1 and 4. Sample 1 was deemed clonally pure. It could
not be called clonally derived because the sequencing depth of the parental cell line HCB‐1 was insufficient to reach a significance threshold of
0.05. Sample 4 was found to be clonally heterogeneous (and thus non‐monoclonal). (d) Fractions of the FG and SG clones measured by qPCR in
Samples 1 and 4, in line with the clonal fractions measured by GTC [Color figure can be viewed at wileyonlinelibrary.com]
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samples. In line with our expectation, the major clonal fraction of the
non‐clonal sample was measured by GTC to comprise 97% of the
sample. As a validation, we independently measured clonal propor-
tions using qPCR assays which confirmed the accuracy of GTC
(Figure 4d). These results show that GTC provides an agnostic and
accurate method that can be used for the assessment of clonality in
the context of standard cell line development procedures, even in the
very unfavorable case of mixed clones bearing highly different dou-
bling times.
3.5 | GTC can be applied in cell line development
procedures involving successive subcloning steps
Current cell line development procedures can involve multiple
transfection and cell cloning steps. For instance, a workflow involving
two successive transfection‐and‐cloning rounds may be applied to
increase cell line productivity (Figure 5a). Moreover, an additional,
final round of cell cloning can be used to ensure the clonal derivation
of a cell line designed for therapeutic protein production. In that case,
applying GTC to the cell line obtained after the second transfection‐
and‐cloning round (SCC1 in Figure 5a) would eliminate the need for a
second cloning step, thereby saving time and resources.
The application of GTC, however, requires that sample‐specific
SNVs be identified. In the present case of two successive rounds of
cloning, the parental population to consider is the cell line obtained
after the first transfection‐and‐cloning round (i.e., SCC0 in Figure 5a),
not the original host cell line. Indeed, if sample‐specific SNVs are
detected by comparison to the host cell line, SNVs identified as fixed
in SCC1 may be already fixed in SCC0. Such SNVs will confound the
estimation of clonal fractions in the case of failed cell cloning because
two potential progenitor cells (from the SCC0 population) will carry
the same SNVs.
In such a cell line development protocol containing multiple
cloning rounds, the parental population is thus freshly clonally de-
rived and its level of genetic diversity is expected to be low. GTC,
however, requires that the parental population contains enough ge-
netic diversity to distinguish potential subclonal populations (Figure
S5a,b). Thus, to determine if GTC may be used, we first characterized
the genetic diversity in cell populations obtained from successive
(a)
(b)
F IGURE 5 Schematic representation of a multistep process used for commercial cell line development (comprised of two transfections and
three rounds of cell cloning) and the genetic evolution of successive subclones. (a) A host cell line is transfected and the transgene (dark blue
triangle) randomly integrates into the genome. Upon cell cloning and expansion (SCC0), a second transfection is performed, resulting in
additional transgene integration sites (light blue triangle) that increase transprotein production. Two final consecutive rounds of cell cloning are
performed to obtain high assurance of clonal derivation for the final cell line (SCC2). (b) Schematic representation of the measured genetic
diversity and evolution during successive rounds of single‐cell cloning and expansion. Single nucleotide variants (SNVs) harbored by the
progenitor cell selected upon the first transfection (green tick) are fixed in the derived cell line (SCC0). However, new SNVs appear during
expansion (orange and blue ticks). The new SNV contained in the next progenitor cell (orange tick) becomes fixed upon expansion of SCC1.
Whole‐genome sequencing revealed 207 such SNVs in the SCC1 cell line. The final round of cell cloning selects a progenitor cell that contains an
SNV (black tick) that appeared during SCC1 expansion and that becomes fixed in SCC2. Whole‐genome sequencing revealed 150 such SNVs in
the SCC2 cell line [Color figure can be viewed at wileyonlinelibrary.com]
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subcloning steps. Specifically, we sequenced three samples from the
same direct lineage (Figure 5a): the cell line obtained after initial
transfection and cell cloning (SCC0), the cell line (SCC1) obtained
from SCC0 re‐transfection and subcloning and the final cell line
(SCC2) obtained from the second consecutive cell cloning. We
identified SNVs fixed in each of the three samples by comparing it to
the host cell line (Figure S6a). We observed that the number of fixed
SNVs steadily increased along this cell lineage, as expected from
several rounds of mutation occurrence and fixation during cloning,
starting at 441 fixed SNVs in SCC0, and increasing to 642 and 783
fixed SNVs in SCC1 and SCC2, respectively (Figure 5b, and see
“Genetic diversity in cell populations obtained from successive sub-
cloning steps” in the Supporting Information and Figure S6b,c).
These results indicated that a newly cloned population subjected
to 6–8 weeks of culture already shows a significant genetic diversity.
We then asked how rare new SNVs were in the parental population,
to make sure that GTC would be able to detect two clonal sub-
populations in the case of failed cell cloning (as each of the two
progenitor cells that would be selected should carry a specific set of
SNVs). Instead of measuring SNV frequency by deep sequencing of
SCC0 cells, we reasoned that if new SNVs contained in SCC0 were
indeed rare, two different SCC1 cell lines obtained from the same
transfection should show very few common, newly fixed SNVs. We
thus sequenced an additional SCC1 cell line obtained from the same
transfection (see “Verification of model specification: potential pre-
sence and influence of shared SNVs” in the Supporting Information
and Figure S5c). This SCC1 sister line displayed 634 fixed SNVs,
comprised of 425 SNVs found to be fixed in SCCO and 209 newly
appeared SNVs. Importantly, all newly fixed SNVs in the sister SCC1
cell line were different from the newly fixed SNVs identified in the
original SCC1 cell line (Figure S5d). This demonstrates that if single‐
cell cloning performed upon the second transfection had failed (and
resulted in the selection of two progenitor cells), each of the two cells
would contain hundreds of SNVs that would be absent from the
other progenitor cell and that would yield a strong signal for GTC to
detect non‐clonality and provide a sensitive measure of clonal frac-
tions. In conclusion, GTC can also be efficiently applied to develop-
ment protocols involving multiple successive cloning steps where the
parental cell line is a recently cloned population.
4 | DISCUSSION
We report the development of a novel method to assess cell line
clonality based on the genome‐wide analysis of SNVs. This genomic
test of clonality requires the genome sequencing of the cell line to be
tested as well as its parental cell line. We validated the clonal frac-
tions measured by GTC using mixtures of two clonal cell lines and
showed that the test is accurate and highly sensitive as it can ro-
bustly detect minor clonal fractions of 1%. Interestingly, GTC does
not require deep sequencing of the test cell line as it leverages the
pooled information gathered over many SNVs. Thus, relatively shal-
low sequencing (i.e., 25× coverage) yields high‐resolution measures of
clonal fractions (i.e., 1% resolution, as fractions of 98% and 99% can
be distinguished) and correspondingly tight confidence intervals.
GTC is a statistically safe procedure as built‐in calculations verify
beforehand that the number and coverage of detected SNVs provide
enough statistical power. Specifically, it ensures that a minor clonal
fraction of 1% can be detected if it is present (see “Operational
threshold for clonal purity” in the Supporting Information).
Cell lines can undergo clonal and genetic evolution, even upon
culturing under constant conditions. For instance, two clonal sub-
populations that originated from the presence of two progenitor cells
at cloning might gradually change in relative abundance over time (as
assessed in our experiment using two clones with very different
growth rates). We cannot exclude, for instance, that a minor clone
having an initially very low growth rate might represent a sub-
threshold fraction (i.e., <1%) at the time of analysis but might later
increase in relative abundance upon subsequent culturing. On the
other hand, a clonally derived cell line might spontaneously become
heterogeneous upon culturing. To avoid potential issues of genetic
evolution, it is thus generally advisable to use GTC on cell lines that
have not been subjected to extended culturing times.
The statistical procedure used in GTC, however, is robust against
SNVs that would newly appear in the cell population after cloning.
Specifically, our method avoids relying on low‐frequency SNVs to
infer clonal fractions. This point was illustrated by applying GTC to
two clonally derived research cell banks (RCBs). Both RCBs were
deemed (clonally) pure (major clonal fractions f = 99.95% and
99.94%). After further development into master cell banks (MCBs),
which involved culturing the two cell populations for several addi-
tional weeks, they were sequenced and subjected to GTC again: The
major clonal fractions estimated by GTC from MCBs (f = 99.96% and
99.85%, respectively) were unchanged compared to what was ob-
tained from the analysis of the RCBs, despite the new SNVs that had
inevitably appeared during further culturing.
For cell populations deemed clonally pure, GTC can provide a
p‐value for clonal‐derivation (“monoclonality”), that is they are de-
rived from a single progenitor cell. Specifically, the confidence for
clonal derivation is inversely related to the frequencies of SNVs in
the parental cell line. The latter can be measured by deep sequencing
of the parental population (e.g. here we used 150× coverage),
yielding significant p‐values for clonal derivation. Alternatively, an
approach combining shallower whole‐genome sequencing of the
parental cell line (which is sufficient for the accurate measurement of
clonal fractions in the derived cell line, see Methods) followed by
deeper, targeted resequencing of a small set of loci might be used to
confirm that at least a small subset of SNVs are very rare in the
parental cell line and thus provide high assurance of clonality. Im-
portantly, we found, however, that most of the specific SNVs fixed in
a clonally derived cell line are at least 10‐fold rarer than what can be
measured by standard high‐throughput sequencing methods, in-
dicating that true p‐values for clonal derivation are even much
smaller than the conservative estimate provided by GTC. Thus, cur-
rently, the overall assurance of clonal derivation provided by GTC is
effectively conditioned by the sensitivity of GTC to detect minor
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clonal fractions (conservatively estimated at 1%), rather than by the
p‐value for clonal derivation as it is comparatively much lower. A
future, formal assessment of LOD (limit of detection) may thus bring
the overall assurance of clonal derivation beyond 99%.
Current methods used for the routine assessment of clonal de-
rivation during cell line development are usually based on the tech-
nical characterization of the cell cloning procedure. When performing
limiting dilution, for instance, the probability of selecting two pro-
genitor cells instead of one can be estimated from the density of the
cell suspension and appropriate probability calculations. Typically, if
one‐third of the wells of the limiting dilution vessel contains cells,
then at least one‐third of the cell populations derived from wells
containing cells are non‐clonal. Imaging cells during the cloning
process can significantly increase the assurance of clonal derivation
(see e.g. the review by Chen et al., 2020). It is not devoid of technical
difficulties though, ranging from optical performance to automated
cell recognition. To date, no method can provide definitive, 100%
assurance of clonal derivation. Furthermore, minor changes in a
process previously characterized to yield clonal populations with a
given probability may also alter statistical confidence, which would
not be detected by the experimenter or regulator a posteriori. The
genetic analysis performed by GTC is the first method that provides
direct characterization of a cell line. Here, we also show an example
application of GTC in the context of cell line development using an
automated imaging and cloning system (Figure 4), which allowed us
to detect non‐clonal samples that were not detected by imaging
alone.
Furthermore, GTC can be applied to protocols involving multiple
cloning steps, such as the subcloning of a recently derived clonal cell
line (e.g. when performing successive rounds of transfection and
cloning). Indeed, our analysis showed that clonal evolution proceeds
at a rate that is sufficient for genetic diversity to reestablish upon
weeks of cell culture only. We hypothesize that the underlying origin
of these mutations corresponds to the known low mutagenesis
background of mismatched bases spontaneously introduced by DNA
polymerase during DNA replication, most of which may be neutral
from an evolutionary and selection perspective. Indeed, we observed
in subclones of recent clonal cell lines that the number of fixed SNVs
was proportional to the culturing time preceding cell cloning
(Figure 5b and “Genetic diversity in cell populations obtained from
successive subcloning steps” in Supplementary Results). Moreover,
SNV frequency spectra measured in host cell lines showed ex-
ponentially decreasing distributions (Figure S2), in line with the
theoretical prediction made for dividing cell populations undergoing
a fixed mutation rate. Note also that this type of mutation frequency
spectrum, with the rarest mutations belonging to the most frequent
mutation type, is ideal for GTC as it ensures with high probability
that two random cells in the population contain a majority of dif-
ferent SNVs thereby allowing for highly sensitive detection of two
clonal subpopulations in the derived cell line.
In conclusion, GTC can be flexibly implemented in the context
of many current cell line development protocols. Given its perfor-
mance, this direct genetic assessment could eliminate the need for a
second round of cell cloning that is often needed to obtain high final
assurance of clonal derivation. GTC thus has the potential to allow
for faster development timelines. The case of routine cell line de-
velopment based on a single transfection of a host cell line could
particularly benefit from the application of GTC: As the same host
cell line is used repeatedly as a parental line, it must be sequenced
only once. Subsequently, shallow sequencing of derived cell lines
combined with GTC can provide a cost‐effective method to obtain
highly characterized cell lines with a high assurance of clonal
derivation.
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